A Pakistani man convicted Friday of plotting to assassinate President Donald Trump and other politicians told an FBI agent he thought Iran ‘was responsible’ for the assassination attempt on Trump in Butler, Pennsylvania. Asif Merchant, 47, told the FBI agent, Jacqueline Smith, that the incident ‘was the same thing he…
President Donald Trump on Friday said the U.S. is ‘doing very well’ in Iran, nearly a week after the military coordinated with Israel on airstrikes in Tehran that left its supreme leader, Ayatollah Ali Khamenei, dead. ‘Somebody said, ‘How would you score it from zero to 10?’ I said, ‘I’d…
Nuvau Minerals Inc. (TSXV: NMC,OTC:NMCPF) (the ‘Company’ or ‘Nuvau’) is pleased to announce that it has closed the second and final tranche of its previously announced brokered private placement pursuant to which the Company issued (i) an aggregate of 7,928,523 common shares of the Company (each, a ‘FT Share’) that…
A new US-Venezuela gold deal could soon channel hundreds of kilograms of bullion from the South American nation into American refineries. Venezuela’s state-owned mining company, Minerven, has agreed to sell between 650 and 1,000 kilograms of gold dore bars to commodities trading house Trafigura under a multimillion-dollar arrangement brokered with…
Here’s a quick recap of the crypto landscape for March 6 as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news. Bitcoin (BTC) was priced at US$68,104.55 down by 4.4 percent over the last 24 hours. Bitcoin…
We also break down next week’s catalysts to watch to help you prepare for the week ahead. In this article: This week’s tech sector performance The tech-heavy Nasdaq Composite (INDEXNASDAQ:.IXIC) navigated a volatile week. Early week caution gave way to a rebound by Monday’s close (March 2), with the Nasdaq…
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of disease-modifying small molecule drug candidates that target CB1CB2 receptors, today announced an update regarding BayMedica LLC (‘BayMedica’), a wholly owned subsidiary of the Company, in light of ongoing uncertainty surrounding U.S. federal…
Peter Krauth, editor of Silver Stock Investor and Silver Advisor, shares his thoughts on silver price activity and where the white metal is in the cycle. He believes the awareness phase is just beginning, with mania still relatively far in the future. Securities Disclosure: I, Charlotte McLeod, hold no direct…
Adrian Day, president of Adrian Day Asset Management, shares his latest thoughts on what’s moving the gold price, emphasizing that its bull run isn’t over yet. ‘It’s monetary factors that are driving gold — that’s what’s fundamentally driving gold,’ he said. ‘Monetary factors, lack of trust in governments and particularly…
Brien Lundin, editor of Gold Newsletter and New Orleans Investment Conference host, shares his stock-picking strategy at a time when high metals prices are beginning to lift all boats. In his view, gold and silver equities may still only be in the second inning. Securities Disclosure: I, Charlotte McLeod, hold…